ClinConnect ClinConnect Logo
Search / Trial NCT01762579

Bio-markers of Not-celiac Wheat Sensitivity

Launched by UNIVERSITY OF PALERMO · Jan 4, 2013

Trial Information

Current as of August 31, 2025

Recruiting

Keywords

Not Celiac Wheat Sensitivity Gluten Esophagogastroduodenoscopy Rectoscopy

ClinConnect Summary

This clinical trial is studying a condition called "not-celiac wheat sensitivity" (NCWS), which affects people who experience symptoms similar to irritable bowel syndrome (IBS) after eating wheat, but do not have celiac disease or a wheat allergy. The researchers want to understand what causes these symptoms and identify specific markers that could help diagnose NCWS. To do this, they will recruit adult patients who have seen their symptoms improve on a gluten-free diet and worsen when they eat gluten again.

Eligible participants for this study are adults between 18 and 65 years old who have IBS-like symptoms that improve when avoiding gluten and who have tested negative for celiac disease and wheat allergy. If you join the study, you will be randomly assigned to receive either wheat flour or a placebo (a harmless substance) for 15 days, and the researchers will monitor your symptoms before and after this period. They will also collect blood and tissue samples to look for possible markers of NCWS. This trial aims to enhance understanding of this condition and improve diagnosis for those affected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients, both genders, with age between 18-65 years, with IBS-like symptoms, that improved on a gluten free diet and worsen on a gluten containing diet
  • Patients testing negative for celiac disease ( anti-tTG and EMA negative, and with biopsy Marsh 0-1) and wheat allergy (serum specific igE for wheat negative)
  • Exclusion Criteria:
  • Subjects diagnosed with celiac disease (positive anti-tTG and/or EMA, and positive histology, with Marsh 2 or above);
  • Subjects diagnosed with wheat allergy (positive serum specific IgE for wheat)
  • Subjects with Type 1 Diabetes
  • Subjects with Inflammatory Bowel Diseases (Crohn's disease or ulcerative colitis)
  • Subjects with Helicobacter pylori infection and other gastrointestinal infection
  • Pregnancy

About University Of Palermo

The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.

Locations

Sciacca, Agrigento, Italy

Palermo, , Italy

Patients applied

0 patients applied

Trial Officials

Antonio Carroccio, PHD, MD

Principal Investigator

Internal Medicine, 'Giovanni Paolo II' Hospital of Sciacca (Agrigento) and University of Palermo, Palermo, Italy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials